Numerous in vitro studies have demonstrated that cancer cell lines are highly dependent on HSF1, with significantly reduced growth rates observed in HSF1-depleted hepatocellular carcinoma (HCC), melanoma, multiple myeloma, malignant peripheral nerve sheath tumors, and in breast and pancreato-biliary cancers [90–95]. Here, HSF1 is linked to AL amyloidosis.